1. Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans. Issue 6 (9th May 2015) Authors: Tarkiainen, EK; Holmberg, MT; Tornio, A; Neuvonen, M; Neuvonen, PJ; Backman, JT; Niemi, M Journal: Clinical pharmacology & therapeutics Issue: Volume 97:Issue 6(2015:Jun.) Page Start: 650 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Glucuronidation Converts Clopidogrel to a Strong Time‐Dependent Inhibitor of CYP2C8: A Phase II Metabolite as a Perpetrator of Drug–Drug Interactions. Issue 4 (27th June 2014) Authors: Tornio, A; Filppula, A M; Kailari, O; Neuvonen, M; Nyrönen, T H; Tapaninen, T; Neuvonen, P J; Niemi, M; Backman, J T Journal: Clinical pharmacology & therapeutics Issue: Volume 96:Issue 4(2014) Page Start: 498 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Grapefruit Juice Inhibits the Metabolic Activation of Clopidogrel. Issue 3 (25th September 2013) Authors: Holmberg, M T; Tornio, A; Neuvonen, M; Neuvonen, P J; Backman, J T; Niemi, M Journal: Clinical pharmacology & therapeutics Issue: Volume 95:Issue 3(2014) Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗